---
title: A low-carbohydrate diet in place of SGLT2i therapy in a patient with diabetic
  cardiomyopathy
date: '2023-12-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38103377/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231217170825&v=2.18.0
source: heidelberg[Affiliation]
description: 'SUMMARY: In patients with diabetes mellitus, the toxic milieu caused
  by abnormal glucose and free fatty acid handling can lead to heart failure (HF).
  Referred to as diabetic cardiomyopathy (DMCM), this syndrome often exists in the
  absence of conventional risk factors for HF such as history of myocardial infarction
  or hypertension. Low-carbohydrate diets (LCDs) have recently been endorsed as an
  efficacious therapeutic dietary approach to prevent and reverse cardiometabolic
  disease including ...'
disable_comments: true
---
SUMMARY: In patients with diabetes mellitus, the toxic milieu caused by abnormal glucose and free fatty acid handling can lead to heart failure (HF). Referred to as diabetic cardiomyopathy (DMCM), this syndrome often exists in the absence of conventional risk factors for HF such as history of myocardial infarction or hypertension. Low-carbohydrate diets (LCDs) have recently been endorsed as an efficacious therapeutic dietary approach to prevent and reverse cardiometabolic disease including ...